key: cord-0694779-41bgc0y7 authors: Dell'Antonia, Massimo; Anedda, Speranza; Usai, Federica; Atzori, Laura; Ferreli, Caterina title: Bullous pemphigoid triggered by COVID‐19 vaccine: Rapid resolution with corticosteroid therapy date: 2021-11-30 journal: Dermatol Ther DOI: 10.1111/dth.15208 sha: 292ab6ea5b21e26492595c38906b7de46ada24b7 doc_id: 694779 cord_uid: 41bgc0y7 nan All authors state that the manuscript is original, it has not been published before and it is not currently being considered for publication elsewhere. Bullous pemphigoid triggered by rabies vaccine Case of pemphigoid with immunoglobulin G antibodies to BP180 Cterminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger Italian guidelines adapted from the EDF/EADV guidelines COVID-19 vaccines: the status and perspectives in delivery points of view Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST) Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination Reply to "psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single Centre Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination